RPG Life Sciences Limited (NSE:RPGLIFE)
India · Delayed Price · Currency is INR 2,636.60
-18.20 (-0.69%)
Aug 21, 2026, 3:29 PM IST
RPG Life Sciences Revenue
RPG Life Sciences had revenue of 1.96B INR in the quarter ending June 30, 2026, with 15.85% growth. This brings the company's revenue in the last twelve months to 7.34B, up 11.78% year-over-year. In the fiscal year ending March 31, 2026, RPG Life Sciences had annual revenue of 7.08B with 8.28% growth.
Revenue (ttm)
7.34B
Revenue Growth
+11.78%
P/S Ratio
5.94
Revenue / Employee
5.38M
Employees
1,366
Market Cap
43.61B
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Mar 31, 2026 | 7.08B | 541.30M | 8.28% |
| Mar 31, 2025 | 6.53B | 713.80M | 12.26% |
| Mar 31, 2024 | 5.82B | 692.40M | 13.50% |
| Mar 31, 2023 | 5.13B | 726.50M | 16.51% |
| Mar 31, 2022 | 4.40B | 510.20M | 13.11% |
| Mar 31, 2021 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| Strides Pharma Science | 50.04B |
| Aarti Pharmalabs | 19.69B |
| Sun Pharma Advanced Research Company | 19.09B |
| Indoco Remedies | 18.73B |
| Innova Captab | 17.49B |
| Solara Active Pharma Sciences | 14.31B |
| Windlas Biotech | 9.42B |
| Orchid Pharma | 8.43B |
RPG Life Sciences News
- 25 days ago - RPG Life Sciences Quarterly report: Q1 2027 - Filings
- 25 days ago - RPG Life Sciences Slides: Q1 2027 - Filings
- 3 months ago - RPG Life Sciences Slides: Investor presentation - Filings
- 4 months ago - RPG Life Sciences Transcript: Q4 25/26 - Transcripts
- 4 months ago - RPG Life Sciences Quarterly report: Q4 2026 - Filings
- 4 months ago - RPG Life Sciences Slides: Q4 2026 - Filings
- 4 months ago - RPG Life Sciences Annual report: Q4 2026 - Filings
- 4 months ago - RPG Life Sciences surges 11% to Rs 2,254 despite 74% profit fall — EBITDA growth and Rs 24 dividend tell the real story - Business Upturn